These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30450823)

  • 41. Berberine: Is it a Promising Agent for Mental Disorders Treatment?
    Shayganfard M
    Curr Mol Pharmacol; 2023; 16(3):307-320. PubMed ID: 35538795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury.
    Chen CC; Hung TH; Lee CY; Wang LF; Wu CH; Ke CH; Chen SF
    PLoS One; 2014; 9(12):e115694. PubMed ID: 25546475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A tribute to Prof. Dr. E. Mutschler. Biocenter Symposium on Drug Therapy: Advances in St. John's Wort Research. February 2000, Frankfurt, Germany.
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S1-156. PubMed ID: 11518054
    [No Abstract]   [Full Text] [Related]  

  • 44. Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis.
    Douglas JA; Follett JM; Parmenter GA; Sansom CE; Perry NB; Littler RA
    Fitoterapia; 2010 Oct; 81(7):925-8. PubMed ID: 20550958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease.
    Och A; Och M; Nowak R; Podgórska D; Podgórski R
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Finding new sources from "using different plants as the same herb": A case study of Huang-lian in Northwest Yunnan, China.
    Zhang Y; Geng YF; Zhang LL; Wang L; He LJ; Wang C; Chai ZZ; Fan RY; Li S; Wang YH
    J Ethnopharmacol; 2015 Jul; 169():413-25. PubMed ID: 25956675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidepressant drugs and cytokines in mood disorders.
    Nishida A; Hisaoka K; Zensho H; Uchitomi Y; Morinobu S; Yamawaki S
    Int Immunopharmacol; 2002 Nov; 2(12):1619-26. PubMed ID: 12469936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.
    Dulawa SC; Janowsky DS
    Mol Psychiatry; 2019 May; 24(5):694-709. PubMed ID: 30120418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Berberine: Pathways to protect neurons.
    Lin X; Zhang N
    Phytother Res; 2018 Aug; 32(8):1501-1510. PubMed ID: 29732634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suicidal Behavior Associated with Mixed Features in Major Mood Disorders.
    Tondo L; Vazquez GH; Baldessarini RJ
    Psychiatr Clin North Am; 2020 Mar; 43(1):83-93. PubMed ID: 32008690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
    Lopresti AL; Hood SD; Drummond PD
    J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia.
    Ghotbi Ravandi S; Shabani M; Bashiri H; Saeedi Goraghani M; Khodamoradi M; Nozari M
    Neurosci Lett; 2019 Jul; 706():151-157. PubMed ID: 31103726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
    Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
    Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabotropic glutamate receptors in the control of mood disorders.
    Witkin JM; Marek GJ; Johnson BG; Schoepp DD
    CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique.
    Pund S; Borade G; Rasve G
    Phytomedicine; 2014 Feb; 21(3):307-14. PubMed ID: 24176841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Affective spectrum disorder?
    Ahuja N
    Am J Psychiatry; 1991 Apr; 148(4):548-9. PubMed ID: 2006708
    [No Abstract]   [Full Text] [Related]  

  • 57. Plant-derived natural medicines for the management of depression: an overview of mechanisms of action.
    Farahani MS; Bahramsoltani R; Farzaei MH; Abdollahi M; Rahimi R
    Rev Neurosci; 2015; 26(3):305-21. PubMed ID: 25719303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Berberine hydrochloride attenuates voluntary methamphetamine consumption and anxiety-like behaviors via modulation of oxytocin receptors in methamphetamine addicted rats.
    Alavijeh MM; Vaezi G; Khaksari M; Hojati V
    Physiol Behav; 2019 Jul; 206():157-165. PubMed ID: 30922821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2007 Aug; 569(1-2):77-83. PubMed ID: 17585901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression.
    Keaton D; Lamkin N; Cassidy KA; Meyer WJ; Ignacio RV; Aulakh L; Blow FC; Sajatovic M
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1087-93. PubMed ID: 19274637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.